Abstract
Detailed crystallographic investigations of three chemically distinct families of drugs with β-adrenergic inhibiting activity have been compared with the results of PCILO calculations and three key features located. The presence of the same features in a β-adrenergic stimulating drug enables us to propose that they define the site responsible for binding to their receptor. In two recently synthesized compounds, the molecule folds in upon itself in order to preserve these features.
ACKNOWLEDGMENT The authors are grateful to D. Watkin (on leave from Oxford University) for correcting the English in the manuscript.
- Copyright © 1980 by The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.